124 related articles for article (PubMed ID: 38486418)
1. Loss of psoas muscle during neoadjuvant treatment for rectal cancer is associated with poor oncological and surgical outcomes.
Yassaie S; Lan R; Hodder R
ANZ J Surg; 2024 Jun; 94(6):1146-1150. PubMed ID: 38486418
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery.
Horie K; Matsuda T; Yamashita K; Hasegawa H; Utsumi M; Urakawa N; Kanaji S; Oshikiri T; Kakeji Y
Eur J Surg Oncol; 2022 Apr; 48(4):850-856. PubMed ID: 34756762
[TBL] [Abstract][Full Text] [Related]
3. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
[TBL] [Abstract][Full Text] [Related]
4. Quick and simple; psoas density measurement is an independent predictor of anastomotic leak and other complications after colorectal resection.
Herrod PJJ; Boyd-Carson H; Doleman B; Trotter J; Schlichtemeier S; Sathanapally G; Somerville J; Williams JP; Lund JN
Tech Coloproctol; 2019 Feb; 23(2):129-134. PubMed ID: 30790102
[TBL] [Abstract][Full Text] [Related]
5. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
[TBL] [Abstract][Full Text] [Related]
6. Is radiological psoas muscle area measurement a predictor of postoperative complications after rectal resection for rectal cancer? A retrospective study.
Uehara H; Yamazaki T; Iwaya A; Kameyama H; Utsumi S; Harada R; Komatsu M; Hirai M; Kubota A; Katada T; Kobayashi K; Sato D; Yokoyama N; Kuwabara S; Otani T
Surg Today; 2022 Feb; 52(2):306-315. PubMed ID: 34309711
[TBL] [Abstract][Full Text] [Related]
7. Decreased total psoas muscle area after neoadjuvant therapy is a predictor of increased mortality in patients undergoing oesophageal cancer resection.
Yassaie SS; Keane C; French SJH; Al-Herz FAJ; Young MK; Gordon AC
ANZ J Surg; 2019 May; 89(5):515-519. PubMed ID: 30959566
[TBL] [Abstract][Full Text] [Related]
8. Patient's Skeletal Muscle Radiation Attenuation and Sarcopenic Obesity are Associated with Postoperative Morbidity after Neoadjuvant Chemoradiation and Resection for Rectal Cancer.
Berkel AEM; Klaase JM; de Graaff F; Brusse-Keizer MGJ; Bongers BC; van Meeteren NLU
Dig Surg; 2019; 36(5):376-383. PubMed ID: 29898443
[TBL] [Abstract][Full Text] [Related]
9. Influence of neoadjuvant treatment strategy on perioperative outcomes in locally advanced rectal cancer.
McFeetors C; O'Connell LV; Choy M; Dundon N; Regan M; Joyce M; Meshkat B; Hogan A; Nugent E
Colorectal Dis; 2024 Apr; 26(4):684-691. PubMed ID: 38424706
[TBL] [Abstract][Full Text] [Related]
10. Limited Role for Routine Restaging After Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Caturegli I; Molin MD; Laird C; Molitoris JK; Bafford AC
J Surg Res; 2020 Dec; 256():317-327. PubMed ID: 32712447
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.
Garlipp B; Ptok H; Schmidt U; Meyer F; Gastinger I; Lippert H
Langenbecks Arch Surg; 2010 Nov; 395(8):1031-8. PubMed ID: 20711786
[TBL] [Abstract][Full Text] [Related]
12. Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?
Dedemadi G; Wexner SD
Dig Dis; 2012; 30 Suppl 2():109-17. PubMed ID: 23207942
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia, as Assessed by Psoas Cross-Sectional Area, Is Predictive of Adverse Postoperative Outcomes in Patients Undergoing Colorectal Cancer Surgery.
Richards SJG; Senadeera SC; Frizelle FA
Dis Colon Rectum; 2020 Jun; 63(6):807-815. PubMed ID: 32149784
[TBL] [Abstract][Full Text] [Related]
14. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
15. Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study.
Bedrikovetski S; Traeger L; Price TJ; Carruthers S; Selva-Nayagam S; Moore JW; Sammour T
J Surg Oncol; 2023 Jul; 128(1):75-84. PubMed ID: 36971689
[TBL] [Abstract][Full Text] [Related]
16. Long-term Oncological Outcomes Following Anastomotic Leak in Rectal Cancer Surgery.
Crippa J; Duchalais E; Machairas N; Merchea A; Kelley SR; Larson DW
Dis Colon Rectum; 2020 Jun; 63(6):769-777. PubMed ID: 32109914
[TBL] [Abstract][Full Text] [Related]
17. Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study.
Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Kishikawa J; Ishii H; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Oba K; Ishihara S
Int J Clin Oncol; 2022 Jan; 27(1):141-153. PubMed ID: 34741193
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and prognosis of anastomotic leak after anterior resection for rectal cancer following neoadjuvant chemoradiotherapy].
Qin QY; Wu YL; Cai YH; Kuang YY; He YJ; Huang XY; Wang H; Ma TH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jun; 24(6):513-522. PubMed ID: 34148316
[No Abstract] [Full Text] [Related]
19. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.
Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488
[TBL] [Abstract][Full Text] [Related]
20. Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial.
Moug SJ; Barry SJE; Maguire S; Johns N; Dolan D; Steele RJC; Buchan C; Mackay G; Anderson AS; Mutrie N
Tech Coloproctol; 2020 Sep; 24(9):959-964. PubMed ID: 32564236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
